Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clomiphene Citrate,Pregnenolone,Dehydroepiandrosterone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
MangoRx to Launch "MOJO" for Low Testosterone & Hormone Imbalances
Details : Mojo (enclomiphene citrate, pregnenolone and dehydroepiandrosterone) is an oral dissolvable tablet aimed at restoring hormonal balance and naturally increasing testosterone levels in men.
Brand Name : Mojo
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 04, 2024
Lead Product(s) : Clomiphene Citrate,Pregnenolone,Dehydroepiandrosterone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Recipient : Emifarma
Deal Size : Undisclosed
Deal Type : Agreement
Mangoceuticals' MangoRx Mexico Signs Agreement for Development Of ED Products
Details : Emifarma will be responsible for initial development & testing of the Company’s Mango ED products a combination of Tadalafil, Oxytocin, and L-Arginine intended for Mexican and Latin American markets.
Brand Name : Mango ED
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 12, 2024
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Recipient : Emifarma
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Testosterone Undecanoate
Therapeutic Area : Endocrinology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
MangoRx Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ Oral TRT Treatment
Details : Prime (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Brand Name : Prime
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 12, 2024
Lead Product(s) : Testosterone Undecanoate
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Boustead Securities
Deal Size : $1.2 million
Deal Type : Public Offering
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering
Details : The Company intends to use the net proceeds to finance the marketing and operational expenses associated with the planned marketing of its Mango ED, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dy...
Brand Name : Mango ED
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 15, 2023
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Boustead Securities
Deal Size : $1.2 million
Deal Type : Public Offering
Lead Product(s) : Sildenafil Citrate,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Mango (sildenafil citrate) mango-flavored, rapid dissolve tablet is a Phosphodiesterase-5 inhibitor, which is being indicated for the treatment of erectile dysfunction.
Brand Name : Mango
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 16, 2023
Lead Product(s) : Sildenafil Citrate,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Greater NY Chamber of Commerce
Deal Size : Undisclosed
Deal Type : Partnership
Details : The partnership aims bring its flagship product, Mango, a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction, to New York.
Brand Name : Mango
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 09, 2023
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Greater NY Chamber of Commerce
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?